This content was published on
Looming US pharma tariffs could challenge the status quo in pharmaceutical hubs like Switzerland as investment shifts to the US.
Slovenia’s role in the global pharmaceutical supply chain
This content was published on
Novartis and Sandoz have been investing into the Balkan nation's pharma sector, turning into a key partner for development and manufacturing of drugs.
